Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer

Article

Deborah Watkins Bruner, PhD, RN, FAAN, from the Nell Hodgson Woodruff School of Nursing at Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Deborah Watkins Bruner, PhD, RN, FAAN, professor, Nell Hodgson Woodruff School of Nursing, Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
Verbal Workflow for Tocilizumab Orders Results in More Timely CRS Intervention

Verbal Workflow for Tocilizumab Orders Results in More Timely CRS Intervention

May 8th 2024
Article

A nurse-driven, verbal workflow to place tocilizumab orders contributed to safer and more effective delivery of tocilizumab for cytokine release syndrome.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Image of a checklist that says FDA.

Tisotumab Vedotin-tftv Approved by FDA in Advanced Cervical Cancer

April 29th 2024
Article

The FDA has approved tisotumab vedotin-tftv for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

Nurse Intervention Approach Feasible in Addressing Cancer Symptom Clusters

April 28th 2024
Article

A pilot study proved that a nurse-coordinated approach shows promise in treating more than just 1 symptom among patients with cancer.

Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma

Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma

April 27th 2024
Article

A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men.

© 2024 MJH Life Sciences

All rights reserved.